176 related articles for article (PubMed ID: 23052245)
1. YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α.
Takeuchi A; Shiota M; Tatsugami K; Yokomizo A; Kuroiwa K; Dejima T; Tanaka S; Itsumi M; Eto M; Naito S
Cancer Immunol Immunother; 2013 Mar; 62(3):517-27. PubMed ID: 23052245
[TBL] [Abstract][Full Text] [Related]
2. STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma.
Ito N; Eto M; Nakamura E; Takahashi A; Tsukamoto T; Toma H; Nakazawa H; Hirao Y; Uemura H; Kagawa S; Kanayama H; Nose Y; Kinukawa N; Nakamura T; Jinnai N; Seki T; Takamatsu M; Masui Y; Naito S; Ogawa O
J Clin Oncol; 2007 Jul; 25(19):2785-91. PubMed ID: 17602083
[TBL] [Abstract][Full Text] [Related]
3. STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma.
Eto M; Kamba T; Miyake H; Fujisawa M; Kamai T; Uemura H; Tsukamoto T; Azuma H; Matsubara A; Nishimura K; Nakamura T; Ogawa O; Naito S;
Eur Urol; 2013 Apr; 63(4):745-52. PubMed ID: 23063454
[TBL] [Abstract][Full Text] [Related]
4. Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α.
Tomita S; Ishibashi K; Hashimoto K; Sugino T; Yanagida T; Kushida N; Shishido K; Aikawa K; Sato Y; Suzutani T; Yamaguchi O
Cancer Sci; 2011 Jan; 102(1):57-63. PubMed ID: 21054677
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory effect of an injectable hyaluronic acid-tyramine hydrogels incorporating human natural interferon-α and sorafenib on renal cell carcinoma cells.
Ueda K; Akiba J; Ogasawara S; Todoroki K; Nakayama M; Sumi A; Kusano H; Sanada S; Suekane S; Xu K; Bae KH; Kurisawa M; Igawa T; Yano H
Acta Biomater; 2016 Jan; 29():103-111. PubMed ID: 26481041
[TBL] [Abstract][Full Text] [Related]
6. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma.
Du Y; Kong C
Cancer Gene Ther; 2021 May; 28(5):502-513. PubMed ID: 33230258
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.
Kong LY; Gelbard A; Wei J; Reina-Ortiz C; Wang Y; Yang EC; Hailemichael Y; Fokt I; Jayakumar A; Qiao W; Fuller GN; Overwijk WW; Priebe W; Heimberger AB
Clin Cancer Res; 2010 May; 16(9):2550-61. PubMed ID: 20388845
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.
Shanmugam MK; Rajendran P; Li F; Kim C; Sikka S; Siveen KS; Kumar AP; Ahn KS; Sethi G
Mol Carcinog; 2015 Oct; 54(10):971-85. PubMed ID: 24797723
[TBL] [Abstract][Full Text] [Related]
9. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
[TBL] [Abstract][Full Text] [Related]
13. [A new interferon-alpha assay system including indirect antitumor effect. Basic and clinical study of renal cell carcinoma].
Yoshihiro S
Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):338-47. PubMed ID: 1564836
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 induces drug resistance in renal cell carcinoma.
Ishibashi K; Koguchi T; Matsuoka K; Onagi A; Tanji R; Takinami-Honda R; Hoshi S; Onoda M; Kurimura Y; Hata J; Sato Y; Kataoka M; Ogawsa S; Haga N; Kojima Y
Fukushima J Med Sci; 2018 Dec; 64(3):103-110. PubMed ID: 30369518
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.
Kawano Y; Takahashi W; Eto M; Kamba T; Miyake H; Fujisawa M; Kamai T; Uemura H; Tsukamoto T; Azuma H; Matsubara A; Nishimura K; Nakamura T; Ogawa O; Naito S
Cancer Sci; 2016 Jul; 107(7):1013-7. PubMed ID: 27089226
[TBL] [Abstract][Full Text] [Related]
16. NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
Hosono T; Tanaka T; Tanji K; Nakatani T; Kamitani T
Br J Cancer; 2010 Mar; 102(5):873-82. PubMed ID: 20160729
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
18. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
[TBL] [Abstract][Full Text] [Related]
19. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-alpha and interleukin-2.
Sonouchi K; Hamilton TA; Tannenbaum CS; Tubbs RR; Bukowski R; Finke JH
Am J Pathol; 1994 Apr; 144(4):747-55. PubMed ID: 8160774
[TBL] [Abstract][Full Text] [Related]
20. Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells.
Chua PJ; Lim JP; Guo TT; Khanna P; Hu Q; Bay BH; Baeg GH
Int J Oncol; 2018 Dec; 53(6):2579-2589. PubMed ID: 30221675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
